STOCK TITAN

[144] Twist Bioscience Corp SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Twist Bioscience Corp (TWST) insider filing reports a proposed sale of 3,000 common shares through Fidelity Brokerage Services LLC with an aggregate market value of $93,450, and an approximate sale date of 10/08/2025 on NASDAQ. The shares were acquired on 10/01/2025 via restricted stock vesting and were paid as compensation. The filer also disclosed three prior open-market sales during the past three months totaling 9,242 shares for gross proceeds of $306,353.08 (sales on 07/09/2025, 08/21/2025, and 10/06/2025). The notice includes the standard representation that the seller is unaware of undisclosed material adverse information.

Twist Bioscience Corp (TWST) una pratica di insider filing segnala una prevista vendita di 3,000 azioni ordinarie tramite Fidelity Brokerage Services LLC con un valore di mercato aggregato di $93,450, e una data di vendita approssimata del 10/08/2025 su NASDAQ. Le azioni sono state acquisite il 10/01/2025 tramite restricted stock vesting e sono state pagate come compensazione. Il compilatore ha inoltre divulgato tre precedenti vendite sul mercato aperto nelle ultime tre mesi, per un totale di 9,242 azioni per proventi lordi di $306,353.08 (vendite il 07/09/2025, 08/21/2025, e 10/06/2025). L’avviso include la dichiarazione standard secondo cui il venditore non è a conoscenza di informazioni avverse sostanziali non divulgate.

Twist Bioscience Corp (TWST) presenta un informe de insider que revela una venta propuesta de 3,000 acciones comunes a través de Fidelity Brokerage Services LLC con un valor de mercado agregado de $93,450, y una fecha de venta aproximada de 10/08/2025 en NASDAQ. Las acciones fueron adquiridas el 10/01/2025 mediante restricted stock vesting y se pagaron como compensación. El informado también divulgó tres ventas previas en el mercado abierto durante los últimos tres meses por un total de 9,242 acciones con ingresos brutos de $306,353.08 (ventas el 07/09/2025, 08/21/2025 y 10/06/2025). El aviso incluye la representación estándar de que el vendedor no está al tanto de información adversa material no divulgada.

Twist Bioscience Corp (TWST)의 내부자 공시는 3,000 주식의 매매가 Fidelity Brokerage Services LLC를 통해 제안되었으며 총 시장 가치는 $93,450, 그리고 10/08/2025의 근사 매도일이 NASDAQ에서 예정되어 있습니다. 해당 주식은 10/01/2025restricted stock vesting를 통해 취득되었고 보상으로 지급되었습니다. 공시는 또한 지난 세 달 동안의 시장가 매매로 총 9,242주를 매도했고 매출총액은 $306,353.08인 세 건의 매도가 있었음을 밝힙니다(07/09/2025, 08/21/2025, 및 10/06/2025). 고지는 매도인이 공개되지 않은 중대한 불리한 정보에 대해 알고 있지 않다는 표준 진술을 포함합니다.

Twist Bioscience Corp (TWST) est l’objet d’un dépôt d’initié annonçant une vente proposée de 3 000 actions ordinaires par l’intermédiaire de Fidelity Brokerage Services LLC avec une valeur de marché aggregate de $93,450, et une date de vente approximative au 10/08/2025 sur le NASDAQ. Les actions ont été acquises le 10/01/2025 via vesting d’actions restreintes et ont été versées comme rémunération. Le déclarant a également divulgué trois ventes antérieures sur le marché libre au cours des trois derniers mois, totalisant 9,242 actions pour un produit brut de $306,353.08 (ventes les 07/09/2025, 08/21/2025, et 10/06/2025). L’avis comprend la déclaration standard selon laquelle le vendeur n’est pas au courant d’informations dommageables importantes non divulguées.

Twist Bioscience Corp (TWST) meldet in einer Insider-Anzeige eine geplante Veräußerung von 3.000 Stammaktien über Fidelity Brokerage Services LLC mit einem aggregierten Marktwert von $93,450 und einem ungefähren Verkaufstermin am 10/08/2025 an der NASDAQ. Die Aktien wurden am 10/01/2025 durch restricted stock vesting erworben und wurden als Vergütung ausgezahlt. Der Antragsteller gab außerdem drei frühere Verkäufe am offenen Markt in den letzten drei Monaten bekannt, insgesamt 9,242 Aktien zu Bruttoerlösen von $306,353.08 (Verkäufe am 07/09/2025, 08/21/2025 und 10/06/2025). Der Hinweis enthält die übliche Darstellung, dass der Verkäufer nicht über undisclosed material adverse information verfügt.

Twist Bioscience Corp (TWST) تقارير ملف insiders يذكر بيعًا مقترحًا لـ 3,000 سهمًا عاديًا من خلال Fidelity Brokerage Services LLC بقيمة سوقية إجمالية قدرها $93,450 وتاريخ بيع تقريبي لـ 10/08/2025 في NASDAQ. تم اكتساب الأسهم في 10/01/2025 عبر restricted stock vesting ودُفعت كـ تعويض. كما كشف المقدم عن ثلاث مبيعات سابقة في السوق المفتوح خلال الأشهر الثلاثة الماضية بمجموع 9,242 سهمًا مع عوائد إجمالية قدرها $306,353.08 (مبيعات في 07/09/2025، 08/21/2025، و 10/06/2025). يتضمن الإشعار تمثيلًا قياسيًا بأن البائع ليس على علم بمعلومات سلبية جوهرية غير مكشوفة.

Twist Bioscience Corp (TWST) 的内幕披露报告显示,拟通过 Fidelity Brokerage Services LLC 出售 3,000 股普通股,市值合计为 $93,450,预计出售日期为 10/08/2025,在 NASDAQ 交易。该等股票于 10/01/2025 通过 restricted stock vesting 获得,作为 薪酬 发放。披露者还披露在过去三个月内的三笔先前的公开市场销售,总计 9,242 股,毛收益为 $306,353.08(分别在 07/09/202508/21/202510/06/2025 的出售)。该通知包括标准表述,卖方并未掌握未披露的重要不利信息。

Positive
  • Vested shares (3,000) were received as compensation on 10/01/2025
  • Sales were executed through a registered broker (Fidelity Brokerage Services LLC) on a major exchange (NASDAQ)
Negative
  • Insider sold 9,242 shares in the past three months for $306,353.08, increasing near-term share supply
  • Planned sale of 3,000 vested shares on 10/08/2025 could further increase available shares

Insights

Insider sold 9,242 shares recently and plans to sell 3,000 vested shares on 10/08/2025.

The filing shows a planned sale of 3,000 shares valued at $93,450, acquired by restricted stock vesting on 10/01/2025. Recent open-market dispositions total 9,242 shares for $306,353.08, indicating the insider has been converting equity compensation to cash over the past quarter.

This pattern increases share supply from an insider in the near term and may modestly affect free‑float dynamics; monitor trading around 10/08/2025 and subsequent filings for additional disposals within the reporting window.

Twist Bioscience Corp (TWST) una pratica di insider filing segnala una prevista vendita di 3,000 azioni ordinarie tramite Fidelity Brokerage Services LLC con un valore di mercato aggregato di $93,450, e una data di vendita approssimata del 10/08/2025 su NASDAQ. Le azioni sono state acquisite il 10/01/2025 tramite restricted stock vesting e sono state pagate come compensazione. Il compilatore ha inoltre divulgato tre precedenti vendite sul mercato aperto nelle ultime tre mesi, per un totale di 9,242 azioni per proventi lordi di $306,353.08 (vendite il 07/09/2025, 08/21/2025, e 10/06/2025). L’avviso include la dichiarazione standard secondo cui il venditore non è a conoscenza di informazioni avverse sostanziali non divulgate.

Twist Bioscience Corp (TWST) presenta un informe de insider que revela una venta propuesta de 3,000 acciones comunes a través de Fidelity Brokerage Services LLC con un valor de mercado agregado de $93,450, y una fecha de venta aproximada de 10/08/2025 en NASDAQ. Las acciones fueron adquiridas el 10/01/2025 mediante restricted stock vesting y se pagaron como compensación. El informado también divulgó tres ventas previas en el mercado abierto durante los últimos tres meses por un total de 9,242 acciones con ingresos brutos de $306,353.08 (ventas el 07/09/2025, 08/21/2025 y 10/06/2025). El aviso incluye la representación estándar de que el vendedor no está al tanto de información adversa material no divulgada.

Twist Bioscience Corp (TWST)의 내부자 공시는 3,000 주식의 매매가 Fidelity Brokerage Services LLC를 통해 제안되었으며 총 시장 가치는 $93,450, 그리고 10/08/2025의 근사 매도일이 NASDAQ에서 예정되어 있습니다. 해당 주식은 10/01/2025restricted stock vesting를 통해 취득되었고 보상으로 지급되었습니다. 공시는 또한 지난 세 달 동안의 시장가 매매로 총 9,242주를 매도했고 매출총액은 $306,353.08인 세 건의 매도가 있었음을 밝힙니다(07/09/2025, 08/21/2025, 및 10/06/2025). 고지는 매도인이 공개되지 않은 중대한 불리한 정보에 대해 알고 있지 않다는 표준 진술을 포함합니다.

Twist Bioscience Corp (TWST) est l’objet d’un dépôt d’initié annonçant une vente proposée de 3 000 actions ordinaires par l’intermédiaire de Fidelity Brokerage Services LLC avec une valeur de marché aggregate de $93,450, et une date de vente approximative au 10/08/2025 sur le NASDAQ. Les actions ont été acquises le 10/01/2025 via vesting d’actions restreintes et ont été versées comme rémunération. Le déclarant a également divulgué trois ventes antérieures sur le marché libre au cours des trois derniers mois, totalisant 9,242 actions pour un produit brut de $306,353.08 (ventes les 07/09/2025, 08/21/2025, et 10/06/2025). L’avis comprend la déclaration standard selon laquelle le vendeur n’est pas au courant d’informations dommageables importantes non divulguées.

Twist Bioscience Corp (TWST) meldet in einer Insider-Anzeige eine geplante Veräußerung von 3.000 Stammaktien über Fidelity Brokerage Services LLC mit einem aggregierten Marktwert von $93,450 und einem ungefähren Verkaufstermin am 10/08/2025 an der NASDAQ. Die Aktien wurden am 10/01/2025 durch restricted stock vesting erworben und wurden als Vergütung ausgezahlt. Der Antragsteller gab außerdem drei frühere Verkäufe am offenen Markt in den letzten drei Monaten bekannt, insgesamt 9,242 Aktien zu Bruttoerlösen von $306,353.08 (Verkäufe am 07/09/2025, 08/21/2025 und 10/06/2025). Der Hinweis enthält die übliche Darstellung, dass der Verkäufer nicht über undisclosed material adverse information verfügt.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did the TWST Form 144 disclose about the proposed sale?

The filing reports a proposed sale of 3,000 common shares valued at $93,450, with an approximate sale date of 10/08/2025 on NASDAQ.

How were the 3,000 shares acquired for TWST?

The shares were acquired on 10/01/2025 by restricted stock vesting and the payment was for compensation.

How many TWST shares did the insider sell in the past three months?

The filer sold a total of 9,242 shares on 07/09/2025, 08/21/2025, and 10/06/2025, for gross proceeds of $306,353.08.

Which broker will handle the proposed TWST sale?

The proposed sale lists Fidelity Brokerage Services LLC (address: 900 Salem Street, Smithfield, RI) as the broker.

Does the filer assert possession of undisclosed material information?

By signing, the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.
Twist Bioscience

NASDAQ:TWST

TWST Rankings

TWST Latest News

TWST Latest SEC Filings

TWST Stock Data

1.88B
59.19M
1.86%
115.89%
16.96%
Diagnostics & Research
Biological Products, (no Disgnostic Substances)
Link
United States
SOUTH SAN FRANCISCO